Sean Adl-Tabatabai – The UK has become the first nation in the world to use BioNTech’s mRNA cancer vaccine to treat the sudden surge in ‘turbo-cancers‘ around the country.
In January, the UK Government announced a new partnership to boost research into mRNA jabs for cancer. From as early as September, UK patients will be among the first in the world to participate in trials of the new mRNA cancer vaccines. Continue reading